Max Frangulov

Recently, Mr. Frangulov was co-Chief Restructuring Officer (CRO) of NMC Healthcare, the largest private healthcare provider in UAE, with revenues of $2 billion. The restructuring and insolvency administration was triggered by a massive fraud by previous beneficiaries and senior executives, resulting in $4.5+ billion of unreported debts of this former FTSE-100 company. Along with the financial restructuring, the mandate required establishing operational control and mobilizing the organization to maintain and improve cost controls, staff retention and efficiency.
Previously, Mr. Frangulov co-led the organization transformation and operational improvement efforts at Fortenova (f.k.a. Agrokor), a major Balkan retail, food production and agriculture conglomerate with 5 billion in revenue. The team worked on design and implementation of new organizational model and introduced processes to monitor and enforce action plans and initiative implementation.
Mr. Frangulov also led the A&M team assisting the equity holders and management of FESCO, one of the largest logistics, container and port operators in Russia, to prepare for the financial restructuring of its Eurobonds and Russian debts. Previously, he led the team responsible for stabilization and operational management of the OAT Group – the largest auto parts manufacturer in Russia and the key supplier of AutoVAZ.
Mr. Frangulov served as CRO of CEDC, one of the world’s largest spirits producers, helping the U.S.-listed company close a going-private sale to a Russian investor and reduce its public bonds from more than $1.3 billion to $650 million. This project received the M&A Advisor Turnaround Award (Chapter 11 Reorganization of the Year) and Turnaround Atlas Award (A&M for Global Turnaround Consulting Firm of the Year).
Mr. Frangulov earned an MBA from the University of Pittsburgh and a master's degree in linguistics from Nizhny Novgorod Linguistic University. He is fluent in Russian and English and proficient in Italian.